Difficult-to-Treat Nephrotic Syndrome in Childhood-Global Depletion of B-Cells.
作者信息
Weber Lutz T, Habbig Sandra, Hackl Agnes
机构信息
Pediatric Nephrology, Children's and Adolescents' Hospital, University Hospital of Cologne, Faculty of Medicine, University of Cologne, Cologne, Germany.
出版信息
Kidney Int Rep. 2024 May 7;9(7):1969-1971. doi: 10.1016/j.ekir.2024.04.064. eCollection 2024 Jul.
Abstract
摘要
相似文献
1
Difficult-to-Treat Nephrotic Syndrome in Childhood-Global Depletion of B-Cells.儿童难治性肾病综合征——B细胞的整体耗竭
Kidney Int Rep. 2024 May 7;9(7):1969-1971. doi: 10.1016/j.ekir.2024.04.064. eCollection 2024 Jul.
2
Gluten-Free Diet in Childhood Difficult-to-Treat Nephrotic Syndrome: A Pilot Feasibility Study.儿童难治性肾病综合征的无麸质饮食：一项初步可行性研究。
Glomerular Dis. 2022 Jun 22;2(4):176-183. doi: 10.1159/000525587. eCollection 2022.
3
Efficacy and safety of rituximab in childhood-onset, difficult-to-treat nephrotic syndrome: A multicenter open-label trial in Korea.利妥昔单抗治疗儿童起病、难治性肾病综合征的疗效与安全性：韩国一项多中心开放标签试验
Medicine (Baltimore). 2018 Nov;97(46):e13157. doi: 10.1097/MD.0000000000013157.
4
Relapse of nephrotic syndrome during post-rituximab peripheral blood B-lymphocyte depletion.利妥昔单抗治疗后外周血B淋巴细胞耗竭期间肾病综合征的复发
Clin Exp Nephrol. 2018 Feb;22(1):110-116. doi: 10.1007/s10157-017-1415-8. Epub 2017 Apr 22.
5
A global antiB cell strategy combining obinutuzumab and daratumumab in severe pediatric nephrotic syndrome.在严重小儿肾病综合征中联合奥滨尤妥珠单抗和达雷妥尤单抗的全球抗 B 细胞策略。
Pediatr Nephrol. 2021 May;36(5):1175-1182. doi: 10.1007/s00467-020-04811-0. Epub 2020 Oct 28.
6
The role of infectious agents in the aetiology and pathogenesis of childhood nephrotic syndrome in Africa.感染因子在非洲儿童肾病综合征病因学及发病机制中的作用
J Infect. 1984 Mar;8(2):100-9. doi: 10.1016/s0163-4453(84)92356-9.
7
Second-line immunosuppressive treatment of childhood nephrotic syndrome: a single-center experience.儿童肾病综合征的二线免疫抑制治疗：单中心经验
Nephron Extra. 2014 Jan 4;4(1):8-17. doi: 10.1159/000357355. eCollection 2014 Jan.
8
Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.每三个月大剂量补充维生素D（每日1000国际单位与400国际单位）对难治性肾病综合征患儿骨质流失的预防作用：一项随机临床试验
Paediatr Int Child Health. 2018 Nov;38(4):251-260. doi: 10.1080/20469047.2018.1505589. Epub 2018 Aug 9.
9
Rituximab Use in the Management of Childhood Nephrotic Syndrome.利妥昔单抗在儿童肾病综合征治疗中的应用
Front Pediatr. 2019 May 10;7:178. doi: 10.3389/fped.2019.00178. eCollection 2019.
10
Idiopathic nephrotic syndrome and rituximab: may we predict circulating B lymphocytes recovery?特发性肾病综合征与利妥昔单抗：我们能否预测循环 B 淋巴细胞的恢复？
Pediatr Nephrol. 2019 Mar;34(3):529-532. doi: 10.1007/s00467-018-4139-4. Epub 2018 Dec 12.
引用本文的文献
1
Shear wave elastography for assessing kidneys in pediatric patients with primary nephrotic syndrome.剪切波弹性成像在评估原发性肾病综合征患儿肾脏方面的应用
Insights Imaging. 2025 Aug 23;16(1):183. doi: 10.1186/s13244-025-02070-x.
本文引用的文献
1
Combined Rituximab and Daratumumab Treatment in Difficult-to-Treat Nephrotic Syndrome Cases.利妥昔单抗与达雷妥尤单抗联合治疗难治性肾病综合征病例
Kidney Int Rep. 2024 Apr 4;9(6):1892-1896. doi: 10.1016/j.ekir.2024.04.006. eCollection 2024 Jun.
2
Long-Term Efficacy and Safety of Rituximab Versus Tacrolimus in Children With Steroid Dependent Nephrotic Syndrome.利妥昔单抗与他克莫司治疗儿童激素依赖型肾病综合征的长期疗效和安全性
Kidney Int Rep. 2023 May 29;8(8):1575-1584. doi: 10.1016/j.ekir.2023.05.022. eCollection 2023 Aug.
3
State of the art in childhood nephrotic syndrome: concrete discoveries and unmet needs.儿童肾病综合征的最新研究进展：具体发现与未满足的需求。
Front Immunol. 2023 Jul 12;14:1167741. doi: 10.3389/fimmu.2023.1167741. eCollection 2023.
4
Use of Rituximab in Childhood Idiopathic Nephrotic Syndrome.利妥昔单抗在儿童特发性肾病综合征中的应用。
Clin J Am Soc Nephrol. 2023 Apr 1;18(4):533-548. doi: 10.2215/CJN.08570722. Epub 2023 Feb 22.
5
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome.国际儿科肾病学会关于儿童激素敏感性肾病综合征诊断和治疗的临床实践建议。
Pediatr Nephrol. 2023 Mar;38(3):877-919. doi: 10.1007/s00467-022-05739-3. Epub 2022 Oct 21.
6
New and Old Anti-CD20 Monoclonal Antibodies for Nephrotic Syndrome. Where We Are?新型及旧型抗 CD20 单克隆抗体治疗肾病综合征：我们已走到哪一步？
Front Immunol. 2022 Feb 11;13:805697. doi: 10.3389/fimmu.2022.805697. eCollection 2022.
7
The Efficacy and Safety of Rituximab for Childhood Steroid-Dependent Nephrotic Syndrome: A Systematic Review and Meta-Analysis.利妥昔单抗治疗儿童激素依赖型肾病综合征的疗效与安全性：一项系统评价和荟萃分析
Front Pediatr. 2021 Aug 20;9:728010. doi: 10.3389/fped.2021.728010. eCollection 2021.
8
Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome.天然抗体和补体激活可作为特发性肾病综合征的特征。
Am J Physiol Renal Physiol. 2021 Oct 1;321(4):F505-F516. doi: 10.1152/ajprenal.00041.2021. Epub 2021 Aug 30.
9
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome.国际儿科肾病学会关于儿童激素耐药型肾病综合征诊断和治疗的临床实践推荐意见。
Pediatr Nephrol. 2020 Aug;35(8):1529-1561. doi: 10.1007/s00467-020-04519-1. Epub 2020 May 7.
Zotero 插件